Additional information
Specialty | |
---|---|
Dosage | |
Form | |
Presentation | |
Primary packaging | |
Specification | |
DCI | |
Classement VEIC | |
Therapeutic class | |
Sub Class | |
Laboratory | |
CHART | |
The duration of the conversation | |
Generic / Princeps | |
AMM |
Symptom relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the overall risks specific to each patient.
Specialty | |
---|---|
Dosage | |
Form | |
Presentation | |
Primary packaging | |
Specification | |
DCI | |
Classement VEIC | |
Therapeutic class | |
Sub Class | |
Laboratory | |
CHART | |
The duration of the conversation | |
Generic / Princeps | |
AMM |